CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 2, March/April 2018
AFRICA
113
Guideline. Report No. 97, 2007.
3.
World Health Organization. Cardiovascular disease. Controlling high
blood pressure, 2015
.
http://www.who.int/cardiovascular_diseases/en/Accessed January 6, 2015.
4.
World Health Organization. Global status report on non-communicable
diseases, 2010. Genera, Switzerland. Accessed February 22, 2015.
5.
World Health Organization. Cardiovascular disease. Strategic priorities,
2015.
http://www.who.int/cardiovascular_diseases/priorities.Accessed
February 22, 2015.
6.
World Health Organization. Cardiovascular diseases. Factsheet No 317,
2015. www.who.int/mediacentre/factsheets/fs317/en/index. Accessed
February 22, 2015.
7.
Morris JN, Heady JA, Raffle PAB, Roberts CG, Parks JM. Coronary
heart disease and physical activity at work.
Lancet
1953;
265
: 1111–1120.
8.
Hannerz H, Tuchsen F. Hospital admissions among male drives in
Denmark.
Occup Environ Med
2001;
58
: 253–260.
9.
Gustavson P, Alfedsson L, Brunnberg H,
et al.
Myocardial infarction
among male bus taxi and lorry bus drivers in middle Sweden.
Occup
Environ Med
1996;
53
: 235–240.
10. Bigert C, Gustavsson P, Hallquist J,
et al
. Myocardial infarction among
professional drivers.
Epidemiology
2003;
14
: 333–339.
11. Tuchen F. Stroke morbidity in professional drivers in Denmark 1981–
1990.
Int J Epidemiol
1997;
26
: 989–994.
12. Sangaleti CT, Trincaus MR, Baratieri T,
et al
. Prevalence of cardiovas-
cular risk factors among truck driver in the South of Brazil.
BMC Public
Health
2014;
14
(1063a): 1–9
.
13. Mohebbi I, Saadat S, Aghassi M,
et al
. Prevalence of metabolic
syndrome in Iranian professional drivers. Results from a population
based study of 12,138 men.
PLoS ONE
2012;
7
(2): e31790.
14. Hirata RP, Malosa Sampio LM, Leitao Filho FS,
et al
. General charac-
teristics and risk factors of cardiovascular disease among interstate bus
drivers.
Sci W J
2012; Article ID 216702: 1–8.
15. Daleva M, Piperova-Dalbokova D, Hadjiolova I,
et al
. Changes in the
excretion of corticosteroids and catecholamines in tractor-drivers.
Int
Arch Occup Environ Health
1982;
49
: 345–352.
16. Sato S
,
Taoda K, Kawamura M,
et al
. Heart rate variability during long
truck driving work.
J Hum Ergol (Tokyo)
2001;
30
: 235–240.
17.
www.citymayor.com(2012).World’s fastest growing cities and urban
areas from 2006–2020. Accessed Feb 13, 2015.
18. Lagos metropolitan area transport. Lagos: Bureau of Statistics.
Digest
of Statistics
, 2010.
19. Amoran OE, Salako EE, Jeminusi O. Screening for common occu-
pational health disease among long distance professional drivers in
Sagamu, Ogun state, Nigeria.
Int J Prev Med
2014;
5
(4): 516–521.
20. Tobin EA, Ofili AN, Asogun DA,
et al
. Prevalence of hypertension and
associated factors among inter-city drivers in an urban city in South-
South Nigeria.
Int J Res Med
2013;
2
(3): 5–12.
21. Erhiano EE, Igbokwe VU, El-Khashab MM, Okolo RU, Awosan KJ.
Prevalence of hypertension among commercial bus drivers in Sokoto,
Sokoto state, Nigeria.
Int J Med Med Sci
2015;
2
(3): 34–39.
22. Ogah OS, Okpechi I, Chukwunoye II. Blood Pressure, prevalence
of hypertension and hypertension related complications in Nigerian
Africans: A
review
. World J Cardiovascular Dis
2012;
4
(12): 327–340.
23.
www.labour.gov.bc.ca/esb/faceshts24. Rolland-Cachera MF, Sempe M, Guilloud-Bataille M, Patois E,
et al.
Adiposity Indices in children.
Am J Clin Nutr
1982;
36
: 178–184.
25. The WHO STEPwise approach to non-communicable disease risk factor
surveillance (STEPS). www.who.int/chp/steps. Accessed April 12, 2015.
26. Ozoh OB, Okubadejo NU, Dania MG. High risk of obstructive sleep
apnea and excessive daytime sleepiness among commercial intra-city
drivers in Lagos metropolis.
Niger Med J
2013;
54
(4): 224–229.
27.
www.randox.com/randox_biosciences.28. American Diabetic Association diagnostic criteria.
www.diabetes.org/diabetes-basic/diagnosis; 2014. Accessed June 19, 2015.
29. National Cholesterol Education Program: ATP III Guidelines 2001.
www.nhlbi.nih.gov/files/docs/guidelines/atp3xsum.pdf. Accessed on
May 20, 2015.
30. Castelli WP, Anderson K, Wilson PW, Levy D. Lipis and the risk of
coronary heart disease. The Framingham Study.
Ann Epidemiol
1992;
2
(1–2): 23–28.
31. www.who.int/steps/resources/GPAQ_Analysis_Guide.pdf. Accessed
May 20, 2015.
32. Adeloye D, Basquill C, Aderemi AV,
et al.
An estimate of the prevalence
of hypertension in Nigeria: a systematic review and meta-analysis.
J
Hypertens
2015;
33
(2): 230–242.
33. Murthy GVS, Fox S, Sivasubramanian S, Gilbert CE, Mahdi AM.
Prevalence and risk factors of hypertension and association with ethnic-
ity in Nigeria: results from a national survey
. Cardiovas J Afr
2013;
24
(9): 344–350.
34. Ekwunife OI, Udeogaranya P, Nwatu I. Prevalence, awareness, treat-
ment and control of hypertension in a Nigerian population.
Health
2010; 2: 731–735.
35. Iseuzo S, Sabir AA, Ohwovoriole AE, Fasanmade OA. Prevalence,
associated factors and relationship between prehypertension and hyper-
tension: a study of two ethnic African populations in northern Nigeria.
J Hum Hypertens
2010;
25
(4): 224–230.
36. Aguiree F, Brown A, Cho NH, Dahlquist G, Dodd S, Dunning T,
et
al.
In:
Guariguata L, Nolan T, Beagley J, Linnenkamp U, Jacqmain
O (eds).
International Diabetes Federation Atlas
. Basel, Switzerland:
International Diabetes Federation, 2013.
37. Ogbera OA, Ekpebegh C. Diabetes Mellitus in Nigeria: The past,
present and future.
World J Diabetes
2014;
5
(6): 905–911.
38. Odenigbo CV, Oguejiofor OC, Odenigbo UM,
et al
. Prevalence of
dyslipidaemia in apparently healthy professionals in Asaba, South-
South Nigeria.
Nig J Clin Pract
2008;
11
: 330–335.
39. Ono T, Guthold R, Strong K. WHO Global Comparable Estimates.
Global Infobase data for saving lives 2005–2012.
https://apps.who.int/infobase/index.aspx. Accessed February 23, 2015.
40. Okafor CI, Gezawa ID, Sabir AA, Raimi TH, Enang O. Obesity, over-
weight and underweight among urban Nigerians.
Nig J Clin Pract
2014;
17
: 743–749.
41. Saberi HR, Moravveji AR, Frakhanan E, Kashani,
et al
. Prevalence of
metabolic syndrome in bus and truck drivers in Kashan, Iran.
Diabetol
Metabolic Syndrome
2011;
3
(1): 8.
42. Hirata RP, Malosa Sampio LM, Leitao Filho FS,
et al
. General char-
acteristics and risk Factors of Cardiovascular Disease among Interstate
Bus Drivers.
Sci W J
2012; Article ID 216702: 1–8.
43. Barbosa PJB, Leaas I, Filho NA, Magalhaes LB, Araujo J. Criteria
for central obesity in a Brazilian population: impact on metabolic
syndrome.
Arq Bras Cardiol
2006;
87
(4): 1–8.
44. Shabnam AA, Homa K, Reza MM, Bagher L,
et al
. Cut-off points for waist
circumference and body mass index for detecting diabetes mellitus, hyper-
cholestrolaemia and hypertension according to the national non-commu-
nicable risk factor surveillance in Iran.
Arch Med Sci
2012;
8
(4): 614–621.
45. Lakshman A, Manikath N, Rahim A, Anilakumari VP. Prevalence and
risk factors for hypertension among male occupational bus drivers in
North Kerla, South India: A cross-sectional study.
ISRN Prev Med
2914; Article 19 318532; 1–9.
46. Zhu S, Kim J, Ma X, Shih A,
et al
. Body mass index and risk of serious
upper body injuries following motor vehicle crashes: concordance of